ClinicalTrials.gg
RecruitingNCT07039812CABGUpdated Jun 26, 2025

The Effect of Virtual Reality and Eye Mask During Dressing After CABG Surgery

An interventional study of Virtual Reality Headset and Eye Mask in CABG, Physiological Parameter and Postoperative Pain, sponsored by Istanbul University - Cerrahpasa. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-06-26.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Registered 3 months after the study started (first participant enrolled Feb 2025, registered Jun 2025).
  • Started Feb 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Pain, Postoperative by Istanbul University - Cerrahpasa — 4 open to participants now, 5 under way, none of them phase 3. Pain, Postoperative · Istanbul University - Cerrahpasa.

Planned enrollment
3rd of 12
90 · median 65
Started
2025
with 2 others
No phase
10 of 18
2 open now
Registered
11th of 18
by date

Among the 18 studies in Pain, Postoperative by Istanbul University - Cerrahpasa, this one is the 3rd largest by planned enrollment of the 12 interventional ones that give a count, is one of 3 that started in 2025, is one of 10 with no phase, and was the 11th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

4 of the 18 studies in Pain, Postoperative by Istanbul University - Cerrahpasa are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Pain, Postoperative by Istanbul University - Cerrahpasa, or all of them as a file.
02

Study summary

This study aims to evaluate the effects of virtual reality (VR) and eye mask (EM) applications on pain, anxiety, and physiological parameters during dressing after Coronary Artery Bypass Graft (CABG) surgery.

Postoperative dressing procedures, especially after sternotomy, often cause significant pain and anxiety in patients. These issues can negatively impact recovery and increase the need for medication. Non-pharmacological interventions such as VR and EM may help reduce these symptoms.

In this randomized controlled trial, 90 patients are divided into three groups: VR group, EM group, and a control group receiving standard care. Pain and anxiety levels are monitored baseline, immediately after, and 15 minutes after both the first and second dressing procedures. Physiological parameters are measured baseline, during, immediately after, and 15 minutes after both dressing procedures. Additionally, analgesic use is followed baseline and immediately after each dressing procedure. The study is conducted in a cardiovascular intensive care unit in Istanbul, Türkiye. It is expected that the findings will support the integration of VR and EM as effective, low-cost, and non-invasive options for postoperative care, improving patient comfort and healthcare quality.

Read the detailed description

This randomized controlled experimental study investigates the effects of virtual reality (VR) and eye mask (EM) applications on sternotomy pain, anxiety, and physiological parameters during postoperative dressing following Coronary Artery Bypass Graft (CABG) surgery.Pain and anxiety during dressing procedures after CABG surgery can negatively affect the recovery process, increase stress responses, prolong hospital stays, and raise the need for medication. Non-pharmacological interventions such as VR and EM are considered effective strategies for managing these symptoms.

The study includes 90 patients, randomly assigned to one of three groups: VR Group: Patients watched 360-degree nature-themed videos using a virtual reality headset during dressing. EM Group: Patients wore an eye mask during dressing. Control Group: Patients received standard care without any additional intervention. The study is being conducted in the Cardiovascular Surgery Intensive Care Unit of a public hospital located in Istanbul, Türkiye.

Inclusion criteria include adult patients undergoing CABG for the first time, ASA classification I-II-III, fully conscious, oriented, cooperative, and willing to provide informed consent. Exclusion criteria include patients with infections or complications, psychiatric disorders, or sensory impairments such as hearing or vision problems. Pain and anxiety levels are assessed at three time points during both the first and second dressing procedures: baseline, immediately after dressing, and 15 minutes after dressing. Physiological parameters (blood pressure, pulse rate, respiratory rate, oxygen saturation) are measured at four time points: baseline, immediately after dressing, and 15 minutes after dressing. Analgesic use is recorded baseline and immediately after each dressing. This study is one of the first to compare VR and EM interventions in the context of high-risk, postoperative cardiac surgery. The results are expected to contribute to evidence-based nursing practices, improve patient comfort in the postoperative period, and support the use of cost-effective, drug-free alternatives for pain and anxiety management in clinical care.

03

Conditions studied

  • CABG
  • Physiological Parameter
  • Postoperative Pain
  • Postoperative Anxiety
  • Coronary Artery Disease

Keywords

  • Coronary Artery Bypass Graft
  • Virtual Reality
  • Eye Mask
  • Pain Management
  • Anxiety
  • Physiological Parameter
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18-65 years
  • First-time coronary artery bypass graft (CABG) surgery for coronary artery disease
  • I, II, or III
  • Conscious, oriented, and cooperative
  • Able to communicate verbally
  • Provided written

Exclusion criteria

Exclusion Criteria:

  • Presence of sternal wound infection or inflammation
  • Intubated at the time of assessment
  • Undergoing revision surgery
  • Receiving anesthesia or sedation in the ICU
  • Experiencing intraoperative or postoperative complications
  • Inability to speak Turkish
  • Hearing or visual impairment
  • Diagnosed psychiatric or cognitive disorder
  • Diagnosis of epilepsy
  • (BMI) ≥ 30
  • Participation in another clinical trial during the same period
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Virtual Reality Group

    Participants in this group will watch 360-degree nature-themed videos through a virtual reality headset (Oculus meta quest 2) during both the first and second sternotomy dressing procedures.

    Device: Virtual Reality Headset

  • Experimental
    Eye Mask Group

    Participants in this group will wear an eye mask during both the first and second sternotomy dressing procedures.

    Device: Eye Mask

  • No intervention
    Control Group

    Participants in this group will receive standard postoperative care during dressing, with no additional interventions applied.

Interventions

  • DeviceVirtual Reality Headset

    During the dressing change, nature-themed videos will be shown through a virtual reality headset that immerses the user in a 360-degree, three-dimensional virtual environment.

  • DeviceEye Mask

    A soft, adjustable, 3D-structured eye mask (Poblex brand) will be applied during the dressing procedure.

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale (VAS)

    Pain intensity will be measured using the Visual Analog Scale (VAS) at three time points: before, immediately after, and 15 minutes after both the first and second sternotomy dressing procedures.

    Time frame: Baseline, immediately after, and 15 minutes after first and second dressing

  2. State-Trait Anxiety Inventory (STAI-II)

    State anxiety levels (STAI-I) will be measured before, immediately after, and 15 minutes after both the first and second dressing procedures. Trait anxiety (STAI-II) will be measured only once, before surgery.

    Time frame: Baseline, immediately after, and 15 minutes after first and second dressing

Secondary outcomes

  1. Physiological Parameters (Blood pressure)

    Blood pressure will be monitored using a monitor device.

    Time frame: Baseline, during, immediately after, and 15 minutes after first and second dressing

  2. Physiological Parameters (Pulse)

    Pulse will be monitored using a monitoring device.

    Time frame: Baseline, during, immediately after, and 15 minutes after first and second dressing

  3. Physiological Parameters (SpO₂)

    Saturation values will be monitored using a monitoring device.

    Time frame: Baseline, during, immediately after, and 15 minutes after first and second dressing

  4. Physiological Parameters (Respiratory rate )

    Respiratory rate will be monitored using a monitoring device.

    Time frame: Baseline, during, immediately after, and 15 minutes after first and second dressing

Other outcomes

  1. Analgesic Use Frequency

    Analgesic agents administered in the intensive care unit, including their names, routes of administration, dosages, and timing, will be systematically documented.

    Time frame: Baseline and immediately after first and second dressing

07

Study locations

1 of 1 sites recruiting
  • Prof. Dr. Cemil Taşçıoğlu City Hospital
    Istanbul, Marmara, Turkey (Türkiye)
    Recruiting
    • Tuğçe Bozkurt Elmas, PhD(c) · Contacttugce.bozkurt10@ogr.iuc.edu.tr · 905063137927
    • Ayfer Özbaş, Professor · Principal investigator
    • Tuğçe Bozkurt Elmas, PhD (c) · Principal investigator
    • Öykü Kara, PhD (c) · Sub investigator
    • İsmail Haberal, Professor · Sub investigator
    • Müge Sezek, MSc · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2025 (actual). Primary completion is estimated for Aug 2025, 6 months after the start.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 6 months is below that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2025
First posted
Jun 26, 2025
StartActual
Feb 24, 2025
Primary completionEst.
Aug 30, 2025
CompletionEst.
Aug 30, 2025
Last update
Jun 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07039812
Collaborators
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Responsible party
Tugce Bozkurt Elmas (PhD Candidate, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Jun 26, 2025
Start date
Feb 24, 2025
Primary completion
Aug 30, 2025 (estimated)
Completion
Aug 30, 2025 (estimated)
Last update
Jun 26, 2025

Study contacts

Tuğçe Bozkurt Elmas, PhD (c)
Contact
tugce.bozkurt10@ogr.iuc.edu.tr
905063137927

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion